Onward Medical Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5.41	1.74	0.53	2.15	1.4
Revenue Growth (YoY)	211.33%	226.88%	-75.23%	53.54%	74.88%
Cost of Revenue	1.04	0.02	15.35	14.69	11.98
Gross Profit	4.38	1.72	-14.82	-12.54	-10.58
Selling, General & Admin	27.21	17.92	15.73	13.74	13.18
Research & Development	18.05	18.64	4.91	5.75	4.78
Operating Expenses	45.26	36.56	20.65	19.49	17.95
Operating Income	-40.89	-34.84	-35.46	-32.03	-28.53
Interest Expense	-2.19	-1.98	-1.38	-1.52	-5.6
Interest & Investment Income	0.58	0.79	0.97	0.06	-
Currency Exchange Gain (Loss)	1.04	0.37	-0.19	-0.02	-0.1
Other Non Operating Income (Expenses)	-0.03	-0.11	-0.02	-0.03	-0.02
Pretax Income	-41.48	-35.77	-36.07	-33.54	-34.25
Income Tax Expense	0.31	-0.04	0.11	-0.77	0.07
Net Income	-41.79	-35.73	-36.18	-32.77	-34.31
Net Income to Common	-41.79	-35.73	-36.18	-32.77	-34.31
Shares Outstanding (Basic)	47	45	30	30	9
Shares Outstanding (Diluted)	47	45	30	30	9
Shares Change (YoY)	4.58%	47.86%	-	218.23%	163.40%
EPS (Basic)	-0.90	-0.80	-1.20	-1.09	-3.62
EPS (Diluted)	-0.90	-0.80	-1.20	-1.09	-3.62
Free Cash Flow	-39.5	-31.91	-32.69	-27.07	-19.97
Free Cash Flow Per Share	-0.85	-0.71	-1.08	-0.90	-2.10
Gross Margin	80.81%	98.73%	-	-	-
Operating Margin	-755.17%	-2003.68%	-6665.98%	-1491.06%	-2039.31%
Profit Margin	-771.83%	-2054.34%	-6800.94%	-1525.70%	-2452.75%
Free Cash Flow Margin	-729.55%	-1835.13%	-6145.11%	-1260.29%	-1427.09%
EBITDA	-40.38	-34.51	-35.23	-31.87	-28.38
D&A For EBITDA	0.51	0.34	0.23	0.16	0.15
EBIT	-40.89	-34.84	-35.46	-32.03	-28.53
Revenue as Reported	5.41	1.74	-	2.15	1.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.